首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Discordant Temporal Evolution of Pfcrt and Pfmdr1 Genotypes and Plasmodium falciparum In Vitro Drug Susceptibility to 4-Aminoquinolines after Drug Policy Change in French Guiana
【2h】

Discordant Temporal Evolution of Pfcrt and Pfmdr1 Genotypes and Plasmodium falciparum In Vitro Drug Susceptibility to 4-Aminoquinolines after Drug Policy Change in French Guiana

机译:法属圭亚那改变药物政策后Pfcrt和Pfmdr1基因型与恶性疟原虫在体外对4-氨基喹啉的药物敏感性不协调的时间演变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Analysis of the evolution of drug target genes under changing drug policy is needed to assist monitoring of Plasmodium falciparum drug resistance in the field. Here we genotype Pfcrt and Pfdmr1 of 700 isolates collected in French Guiana from 2000 (5 years after withdrawal of chloroquine) to 2008, i.e., the period when the artemether-lumefantrine combination was progressively introduced and mefloquine was abandoned. Gene sequencing showed fixation of the 7G8-type Pfcrt SMVNT resistance haplotype and near fixation of the NYCDY Pfdmr1 haplotype. Pfdmr1 gene copy number correlated with 50% inhibitory concentrations of mefloquine and halofantrine (r = 0.64 and 0.47, respectively, n = 547); its temporal changes paralleled changes in in vitro mefloquine susceptibility. However, the molecular parameters studied did not account for the regained in vitro susceptibility to chloroquine and showed a poor correlation with susceptibility to artemether, lumefantrine, or quinine. Identification of novel markers of resistance to these antimalarials is needed in this South American area.
机译:需要在不断变化的药物政策下分析药物靶基因的进化,以协助现场监测恶性疟原虫的耐药性。在这里,我们对2000年(撤出氯喹的5年后)至法属圭亚那收集的700株分离株的Pfcrt和Pfdmr1进行了基因分型,即逐步引入了蒿甲醚-荧光粉组合并放弃了甲氟喹的时期。基因测序显示固定了7G8型Pfcrt SMVNT抗性单倍型,而固定了NYCDY Pfdmr1单倍型。 Pfdmr1基因拷贝数与甲氟喹和氟替林的50%抑制浓度相关(r分别为0.64和0.47,n = 547);它的时间变化与体外甲氟喹敏感性的变化平行。然而,所研究的分子参数并不能解释体外对氯喹的敏感性,并且与蒿甲醚,lumantantrine或奎宁的敏感性相关性较差。在这个南美地区,需要鉴定出对这些抗疟药具有抗性的新标记。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号